NPI: 1437350451 · CORAL GABLES, FL 33134 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/29/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/29/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,310 | $1.64M |
| 2019 | 18,683 | $3.16M |
| 2020 | 15,473 | $1.95M |
| 2021 | 11,384 | $841K |
| 2022 | 8,468 | $995K |
| 2023 | 1,078 | $198K |
| 2024 | 330 | $18K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,102 | 1,423 | $2.73M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 20,363 | 1,073 | $2.64M |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,782 | 1,083 | $1.65M |
| A4657 | Syringe, with or without needle, each | 2,750 | 1,160 | $586K |
| J1756 | Injection, iron sucrose, 1 mg | 3,450 | 629 | $308K |
| 85041 | 1,288 | 910 | $161K | |
| 85048 | 1,162 | 823 | $149K | |
| 82728 | 1,147 | 819 | $146K | |
| 83540 | 1,131 | 813 | $137K | |
| 83550 | 1,126 | 810 | $135K | |
| 83970 | 1,082 | 738 | $131K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 239 | 138 | $22K |
| 82108 | 89 | 72 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 15 | 13 | $0.00 |